MyFinsight
Home
About
Contact
lgnyz: the income statement
Download
Download image
Financial Royalty Assets
$6,425K
Intangible Royalty Assets
$40,161K
Contract Revenue And
Other Income
$58,203K
Material Sales Captisol
$10,672K
Royalty
$46,586K
Interest income
$3,874K
Gain (loss) from
change in fair value of...
$75,887K
Gain (loss) from
short-term investments
$7,798K
Total revenues and
other income
$115,461K
Total non-operating
income (expenses), net
$86,206K
Operating income (loss)
$54,931K
Other non-operating
expense, net
-$443K
Interest expense
$910K
Total operating costs
and expenses
$60,530K
Fair value
adjustments to partner...
$833K
Income (loss) before
income taxes
$141,137K
General and
administrative
$28,446K
Research and development
$21,019K
Amortization of intangibles
$8,097K
Cost of captisol
$3,801K
Net income (loss)
$117,273K
Income tax expense
$23,864K
Back
Back
Income Statement
source: myfinsight.com
LIGAND PHARMACEUTICALS INC (LGNYZ)
LIGAND PHARMACEUTICALS INC (LGNYZ)